Tag: Alkermes Plc

  • Drug Delivery Stocks: Delcath Systems (NASDAQ:DCTH), Generex Biotechnology Corporation (OTCMKTS:GNBT), Alkermes Plc (NASDAQ:ALKS), Valeant Pharmaceuticals Intl Inc (NYSE:VRX)

    Delcath Systems, Inc. (NASDAQ:DCTH) gained 7.61% after Form SC 13G/Awas filed by SABBY MANAGEMENT, LLC. Delcath Systems, Inc. (NASDAQ:DCTH) stock opened at $0.33 in last session, and closed at $0.311, while the day range of DCTH stock is $0.31 – $0.35. The stock showed a negative weekly performance of -8.53%.

    Generex Biotechnology Corporation (OTCMKTS:GNBT) remains under spotlight as it focuses on getting its breast cancer vaccine on the market. Generex Biotechnology Corporation (OTCMKTS:GNBT) stock opened at $0.04, in last session and closed at $0.0424, by gaining 0.47%. The 52 week range of GNBT is $0.02 – $0.07. Company’s market capitalization is $26.28million.

    Alkermes PLC (NASDAQ:ALKS) had its price objective hosited by Leerink Swann from $46.00 to $58.00 in a report released on Friday. Alkermes Plc (NASDAQ:ALKS) stock decreased -2.01% and finished the last session at $48.68. The EPS of the stock remained 0.13. Company’s market capitalization is $6.61billion.

    Canada’s main stock index edged higher on Tuesday as Valeant Pharmaceuticals Intl Inc (NYSE:VRX) gained after a report indicated its interest in a unit of Pfizer Inc Intl Inc (NYSE:VRX) and telecoms shares rose after Globalive pulled out of a wireless auction. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock opened the session at $134.27, and closed the session at $135.64. The 52 week range of the VRX stock remained $64.05 – $140.36 and the day range was $132.85 – $137.35.